Prakash Neupane

1PUBLICATIONS
10CO-AUTHORS
Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (1)

|Aug 19, 2026
Danvatirsen plus pembrolizumab versus pembrolizumab for recurrent and/or metastatic head and neck squamous cell carcinoma (PEMDA-HN): a randomized, phase 2 trial.

Pageof 1

Frequent Collaborators

1 joint publications

Nabil F Saba

1 joint publications

Marshall Posner

1 joint publications

Kevin Harrington

1 joint publications

Rod Rezaee